Delivery Order SPE2DB22D2211-SPE2DB25FSCTE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $9,438.39 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $8,218.23 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of VEVYE 0.1% eye drops in 2ml quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) with a ceiling value of $1,715.49 under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) with a ceiling value of $2,509.24. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,519.02 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Vevye 0.1% eye drop solution (2ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $4,116.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vevye 0.1% eye drop solution (2mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order represents a child...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCTEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor based in Conshohocken, Pennsylvania, for supply of VEVYE 0.1% eye drops in 2ML units. This firm fixed-price delivery order, valued at $6,967.04, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The award represents a continuation of the company's role as a critical vendor within the federal medical supply chain, fulfilling pharmaceutical procurement needs for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. The parent contract enables the company to supply an extensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a key provider alongside other contractors in this strategic healthcare procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 8/12/25 |